A new sustained-release tablet formulation of procainamide.

Suppr

超能文献

作者信息

Fremstad D, Dahl S, Jacobsen S, Lunde P K, Nådland K J, Marthinsen A A, Waaler T, Landmark K H

出版信息

Eur J Clin Pharmacol. 1973 Dec;6(4):251-5. doi: 10.1007/BF00644741.

DOI:10.1007/BF00644741

PMID:4591152

Abstract

摘要

相似文献

A new sustained-release tablet formulation of procainamide.

Eur J Clin Pharmacol. 1973 Dec;6(4):251-5. doi: 10.1007/BF00644741.

Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.

Acta Med Scand. 1974 Mar;195(3):217-22. doi: 10.1111/j.0954-6820.1974.tb08125.x.

Experiences on a sustained-release procainamide preparation.关于一种普鲁卡因胺缓释制剂的经验。

Curr Ther Res Clin Exp. 1973 Oct;15(10):707-12.

Plasma levels of procaine amide after administration of conventional and sustained-release tablets.

Eur J Clin Pharmacol. 1973 Dec;6(4):245-50. doi: 10.1007/BF00644740.

[Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].

Ugeskr Laeger. 1976 Sep 27;138(40):2433-7.

[Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].[口服普鲁卡因胺治疗室性心律失常。使用片剂（普罗奈斯特）和缓释制剂（普鲁卡因胺长效片）期间的血浆浓度]

Ugeskr Laeger. 1976 Sep 27;138(40):2425-33.

Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.

J Pharm Sci. 1974 Dec;63(12):1958-9. doi: 10.1002/jps.2600631231.

Pharmacokinetic of procainamide in man.普鲁卡因酰胺在人体中的药代动力学。

Ann N Y Acad Sci. 1971 Jul 6;179:370-82. doi: 10.1111/j.1749-6632.1971.tb46914.x.

Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type.

Curr Ther Res Clin Exp. 1975 Nov;18(5):720-6.

Pharmaceutical and pharmacokinetic principles in the formulation of a sustained-release procainamide tablet.

Pharm Acta Helv. 1976;51(7-8):204-8.

引用本文的文献

Procainamide absorption studies to test the feasibility of using a sustained-release preparation.进行普鲁卡因胺吸收研究以测试使用缓释制剂的可行性。

Br J Clin Pharmacol. 1975 Dec;2(6):515-9. doi: 10.1111/j.1365-2125.1975.tb00569.x.

Acetylation of procaine amide in man. A preliminary communication.普鲁卡因酰胺在人体内的乙酰化。初步报告。

Eur J Clin Pharmacol. 1975;8(1):79-81. doi: 10.1007/BF00616419.

Comparison of the acetylation of procainamide and sulfadimidine in man.人体内普鲁卡因酰胺和磺胺二甲嘧啶乙酰化作用的比较。

Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):433-8. doi: 10.1007/BF00606561.

A pharmacokinetic comparison of two sustained-release oral procainamide preparations.两种口服普鲁卡因胺缓释制剂的药代动力学比较。

Br J Clin Pharmacol. 1979 Sep;8(3):267-71. doi: 10.1111/j.1365-2125.1979.tb01013.x.

Clinical pharmacokinetics of procainamide.普鲁卡因胺的临床药代动力学。

Clin Pharmacokinet. 1978 Mar-Apr;3(2):97-107. doi: 10.2165/00003088-197803020-00001.

Significance of the acetylation phenotype and the therapeutic effect of procainamide.

Eur J Clin Pharmacol. 1979 Feb 19;15(1):63-8. doi: 10.1007/BF00563559.

本文引用的文献

Pharmacokinetic of procainamide in man.普鲁卡因酰胺在人体中的药代动力学。

Ann N Y Acad Sci. 1971 Jul 6;179:370-82. doi: 10.1111/j.1749-6632.1971.tb46914.x.

Procainamide dosage schedules, plasma concentrations, and clinical effects.普鲁卡因胺的给药方案、血浆浓度及临床效果。

JAMA. 1971 Mar 1;215(9):1454-60.

Relation of hydralazine plasma concentration to dosage and hypotensive action.肼屈嗪血浆浓度与剂量及降压作用的关系。

Clin Pharmacol Ther. 1972 May-Jun;13(3):420-5. doi: 10.1002/cpt1972133420.

Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.肼屈嗪治疗的高血压患者中乙酰转移酶活性与抗核抗体及毒性症状的关系。

J Lab Clin Med. 1970 Jul;76(1):114-25.

Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.急性心肌梗死中使用普鲁卡因胺进行抗心律失常预防。

N Engl J Med. 1969 Dec 4;281(23):1253-60. doi: 10.1056/NEJM196912042812301.

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.

Ann Intern Med. 1973 Feb;78(2):183-93. doi: 10.7326/0003-4819-78-2-183.

[Arrhythmia prophylaxis with procanamide: inadequate dosage?].[用普鲁卡因酰胺预防心律失常：剂量不足？]

Lakartidningen. 1972 Jun 12;69:Suppl 2:47-50.

Metabolism of procainamide in rhesus monkey and man.普鲁卡因酰胺在恒河猴和人类中的代谢。

Clin Pharmacol Ther. 1972 May-Jun;13(3):366-71. doi: 10.1002/cpt1972133366.

Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.与普鲁卡因胺治疗相关的狼疮样综合征，伴有持续的免疫异常。

Can Med Assoc J. 1972 Aug 19;107(4):312-5.

Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.肼屈嗪诱导的红斑狼疮中对肼屈嗪和核抗原的免疫反应。

Ann Intern Med. 1972 Mar;76(3):365-74. doi: 10.7326/0003-4819-76-3-365.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验